- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07309250
A Study on Gastrointestinal Transit Time at the Population Level (GITTPop)
Gastrointestinal Transit Time at the Population Level: A Cross-sectional Study
The goal of this study is to investigate the baseline of gastrointestinal transit time (GITT) and explore its relationship with other health indicators in 932 healthy adult volunteers.
The main questions it aims to answer are:
What are the population-level baseline values for GITT using the blue dye method? How is GITT associated with key physiological parameters including blood metabolic markers, life style, and stool characteristics?
Participants will:
Consume a standardized blue dye muffin after overnight fasting at the research center; Offer a finger prock blood samples for metabolic profiling; Collect stool samples for moisture measurement; Complete detailed questionnaires on diet, lifestyle, and bowel habits; Record the time of first blue stool appearance to determine GITT.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This explorative study is designed as a cross-sectional investigation aimed at establishing population-level reference values for gastrointestinal transit time (GITT). Adult participants from the general population will undergo GITT measurement using the blue-dye method. This muffin contains blue colorant that cannot be absorbed; after ingestion, it passes through the entire gastrointestinal tract and is eventually excreted in feces. Following a two-day lifestyle standardization period (including dietary and activity guidance) to minimize potential confounding effects on gastrointestinal motility, participants will attend a clinical visit where they will ingest a blue muffin. GITT will be determined by measuring both the time interval between ingestion of the blue muffin and the first appearance of blue-colored stool, and the duration from its first appearance to its complete disappearance.
The blue muffin method has been well-established in previous research for GITT assessment. Building upon the methodology developed by Berry et al., we will introduce stricter pre-test condition controls (includes dietary advice and lifestyle recommendations) and optimized the blue muffin formulation.These improvements allow for reliable measurement with a single muffin administration, which has been evaluated through KU Leuven Health Pass in a large sample size(S-70168).
To investigate potential determinants and correlates of GITT, we will collect biochemical parameters, fecal moisture, and resting metabolic rate. Additionally, participants will complete 24-h diet record and health questionnaires assessing bowel movement, physical activity habits, stress levels, sleep quality and hydration condition for subsequent correlation analyses.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Christophe Matthys
- Phone Number: +32 016342655
- Email: christophe.matthys@uzleuven.be
Study Contact Backup
- Name: Wei Li
- Phone Number: +32 016344539
- Email: wei.li2@kuleuven.be
Study Locations
-
-
Flemish Brabant
-
Leuven, Flemish Brabant, Belgium, 3000
- Department of Chronic Diseases and Metabolism
-
Contact:
- Wim Janssens
- Phone Number: +32 016252111
- Email: wim.janssens@kuleuven.be
-
Contact:
- Evelyne van Etten
- Phone Number: +32 016330855
- Email: evelyne.vanetten@kuleuven.be
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- 18-65 years old
- 18.5 kg/m² ≤ BMI ≤ 25 kg/m² or BMI ≥ 30 kg/m² (people with normal weight or obesity)
- Provision of informed consent to participate.
Exclusion Criteria:
- Gastrointestinal conditions which may affect nutrient absorption or gastric emptying, including coeliac disease, Crohn's disease, previous resection of the small intestine other than bariatric surgery, gastroparesis;
- Using medications which effect gastric motility (e.g., domperidone, erythromycin, metoclopramide, prucalopride, opiates, loperamide, …)
- The ingredients of blue muffins include gluten, nuts, baking powder, sugar, vanilla extract and sunflower oil. Participants with allergies to these ingredients;
- Current diagnosis of cancer;
- Advanced organ failure, including chronic kidney disease Stage 5, liver cirrhosis Child-Pugh B or C, intestinal failure, heart failure stage D, or chronic obstructive pulmonary disease stage 4;
- Immobility;
- Neuromuscular degenerative conditions associated with muscular atrophy, such as myasthenia gravis, muscular dystrophies, fibromyalgia, or multiple Sclerosis;
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Adult participants
Healthy adult participants without serious gastrointestinal diseases
|
Participants will consume a regular muffin containing blue dye
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gastrointestinal transit time
Time Frame: From enrollment to the end of study at 2 weeks
|
Calculate the transit time by the recorded muffin consuming time, first blue stool appearance time and last blue stool appearance time
|
From enrollment to the end of study at 2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Height (cm)
Time Frame: baseline
|
Measured using a height meter, in centimeters.
|
baseline
|
|
Weight (kg)
Time Frame: baseline
|
Measuring using a scale, in kg.
|
baseline
|
|
BMI
Time Frame: baseline
|
weight and height will be combined to report BMI in kg/m^2
|
baseline
|
|
Blood glucose (mmol/L)
Time Frame: baseline
|
Measure blood glucose by CardioChek Plus in mmol/L
|
baseline
|
|
Fat mass (kg)
Time Frame: baseline
|
Using Bodystat quadscan 4000 to measure fat mass (kg)
|
baseline
|
|
Lean body mass(kg)
Time Frame: baseline
|
Using Bodystat quadscan 4000 to measure lean body mass (kg)
|
baseline
|
|
Fat percentage (%)
Time Frame: baseline
|
Using Bodystat quadscan 4000 to measure fat%
|
baseline
|
|
Total cholesterol (mmol/L)
Time Frame: baseline
|
Measuring by Mission cholesterol Meter in mmol/L
|
baseline
|
|
HDL-C (mmol/L)
Time Frame: baseline
|
Measuring by Mission cholesterol Meter in mmol/L
|
baseline
|
|
LDL-C (mmol/L)
Time Frame: baseline
|
Measuring by Mission cholesterol Meter in mmol/L
|
baseline
|
|
Triglyceride (mmol/L)
Time Frame: baseline
|
Measuring by Mission Cholesterol Meter in mmol/L
|
baseline
|
|
Food record
Time Frame: 2 days after study
|
Participants record their 24-h diets through smartphone application
|
2 days after study
|
|
Stool form
Time Frame: baseline
|
Stool form will be evaluated by Bristol Stool Form Scale, the score is from 1 to 7, with values closer to the middle indicating more ideal stool shape.
|
baseline
|
|
Hydration status
Time Frame: baseline
|
Hydration status will be rated from 1 to 8 by Urine color chart, with higher numbers indicating that the body needs more water.
|
baseline
|
|
Perceived level of stress
Time Frame: baseline
|
The10-item Perceived Stress will be used to measures an individual's perceived level of stress over the past month.
The total score ranges from 0 to 40.
A higher score indicates a greater perceived level of stress.
|
baseline
|
|
Sleep quality
Time Frame: baseline
|
Pittsburgh Sleep Quality Index will be used to assess subjective sleep quality over the past month.
The total score ranges from 0 to 21.
A higher score indicates poorer sleep quality.
|
baseline
|
|
Activity level
Time Frame: baseline
|
The Baecke Physical Activity Questionnaire will be used to assess daily habitual physical activity, with a particular focus on work-related and exercise-related activities.
It does not produce a single total score, but rather scores on three dimensions, each typically ranging from 1 to 5. On each dimension, a higher score indicates a higher level of physical activity in that area.
Therefore, for assessing activity levels, a higher score is generally better.
|
baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- S70908
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Transit Time
-
University of AarhusMotilis,SwitzerlandCompletedGastric Emptying | Gastrointestinal Motility | Total Gastrointestinal Transit Time | Segmental Transit TimeDenmark
-
University of FloridaCompletedGastrointestinal Symptoms | Stool Frequency | Gastrointestinal Transit TimeUnited States
-
The First Affiliated Hospital of Zhejiang Chinese...CompletedGastric Transit Time | Small-bowel Transit TimeChina
-
AstraZenecaCompletedFood Effect | Gastric Emptying Time | Magnetic Marker Monitoring | Gastrointestinal-transport | Small Intestinal Transit Time | Time for Colon ArrivalGermany
-
Winthrop University HospitalTerminatedGastric Transit TimeUnited States
-
Uppsala UniversityUnknown
-
Federal University of Minas GeraisCompletedGastric Emptying | Intestinal Transit TimeBrazil
-
University Hospital Schleswig-HolsteinCompletedHemodynamics | Surgery in Elderly Patients | Pulse Wave Transit TimeGermany
-
Penn State UniversityDairy Management Inc.CompletedDelayed Transit Time | Irregular Bowel FunctionUnited States
-
Weill Medical College of Cornell UniversityMedistim ASARecruitingCABG | Heart Disease | Blood Flow | CABG Graft Integrity | Transit-time Flow MeasurementUnited States
Clinical Trials on Diet
-
Medical University of WarsawCompletedDietary Intervention | Metabolic Cardiovascular Syndrome | Vegetarian Diet | Mediterranean Diet | Vegan Diet | Obesity and OverweightPoland
-
Maastricht University Medical CenterNational Cattlemen's Beef AssociationRecruitingMuscle Protein Synthetic Response to ProteinNetherlands
-
Laval UniversityDairy Farmers of Canada; Agriculture and Agri-Food CanadaCompleted
-
Universidad del Centro Educativo LatinoamericanoUniversidad Nacional de RosarioRecruitingNutrition | Cardiovascular (CV) Risk | Cardiometabolic Health IndicatorsArgentina
-
Tufts Medical CenterCompletedObesity | Cardiovascular Disease | Metabolic Syndrome
-
University of PittsburghCompletedCardiovascular Diseases | ObesityUnited States
-
Indiana University School of MedicineNational Institutes of Health (NIH)Completed
-
University of MichiganNot yet recruitingIrritable Bowel SyndromeUnited States
-
Burke Rehabilitation HospitalCompletedStroke | Ischemic StrokeUnited States
-
Medical University of GdanskNot yet recruitingAsthma | Dietary Intervention | Vegan Diet